Applied DNA Sciences, Inc. (OTCMKTS:APDN) Continues Its Descent
Applied DNA Sciences, Inc. (OTCMKTS:APDN)’s stock has been descending the charts since mid-May and we rarely see it close in the green. Back then it peaked at $0.264 on May 15 before it started to slide down. The financial report that was filed in August didn’t make things better and the total loss in value that APDN has recorded in the period amounts to 65%.
Most recently APDN‘s stock saw some investor interest after the October 2 press release with which the company informed the public that it has signed its fifth original component manufacturer contract, allowing SigNature® DNA marking of parts under the Defence Logistics Agency reguirement.
The boost in price was little with only 6.32%, but the amount of shares came at a whopping 9.7 million, which was the highest in more than 3 months and helped generate a trade value of 997 thousand dollars.
After that the stock resumed its downward slide registering a minor gain of 2.06% in Friday’s session. APDN opened this week with a loss of 5.05% continuing the path that the company stock has taken. The total amount of shares that switched hands came at 2.8 million and helped generate a trade value of $269.
The ticker is likely to continue moving the same way in anticipation of the next financial report. Here is a quick reminder of the numbers of prime interest from APDN‘s Q2 report for those of you who haven’t followed our coverage on the company.
- cash: $1.8 million
- current assets: $2.5 million
- current liabilities: $1.5 million
- quarterly revenue: $644 thousand
- quarterly net loss: $2.1 million
- accumulated deficit: $182 million
Now, as many of you might say that they have a decent amount of cash and are generating revenue we must remind you that in just 3 months, APDN somehow managed to spend more than half of their cash, while in the meantime increasing current liabilities by around 90%.
With its current stock price and the fact that the company is generating revenue APDN is all set for a paid promotion, so beware. It may quickly turn sour if the promotion comes before the new financial report and you might end up with high losses.
On the other hand Titan Pharmaceuticals, Inc. (OTCBB:TTNP) is gathering more and more momentum in an upward direction on high volumes of traded stock. Globalstar, Inc. (OTCMKTS:GSAT), barely moving in price is still in the top of OTC stocks that generate highest dollar volume as it has been for a while now.
